Your account is not claimed yet. You can sign up with ORCID to claim your account.

Kasper Mølgaard Jensen (Kasper Mølgaard)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum Stress

Tyrosine Kinase

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Cancer immunology, immunotherapy : CII

Herlev Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Herlev Hospital Apr 1o 2017

Denmark

PhD student :: Center for cancer Immunotherapy

Publications

Simone Kloch Bendtsen, Maria Perez-Penco, Mie Linder Hübbe, Evelina Martinenaite, Morten Orebo Holmström, Stine Emilie Weis-Banke, Nicolai Grønne Jørgensen, Mia Aaboe Jørgensen, Shamaila Munir Ahmad, Kasper Mølgaard Jensen, Christina Friese, Mia Thorup Lundsager, Astrid Zedlitz Johansen, Marco Carretta, Niels Odum, Özcan Met, Inge Marie Svane, Daniel Hargbøl Madsen, Mads Hald Andersen
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment. Oncoimmunology 11 (1) (2022)
Kasper Mølgaard Jensen, Seandean L Harwood, Marta Compte, Nekane Merino, Jaume Bonet, Ana Alvarez-Cienfuegos, Kasper Mikkelsen, Natalia Nuñez-Prado, Ana María Álvarez-Méndez, Laura Sanz, Francisco J Blanco, Luis Alvarez-Vallina
Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies. Cancer immunology, immunotherapy : CII 67 (8) (2018)